QuintilesIMS Real-World Insights Bibliography

Impact of adalimumab’s patient support program on clinical outcomes in inflammatory bowel diseases: Results from the COMPANION study
Author(s): Marshall JK1, Narula N1, Millson B2, Charland K2, Sung M2, Gaetano T3, McHugh K3, Latour M3, Laliberté MC3
Affiliations(s): 
Publication(s): European Crohn’s and Colitis Organization 2017 Conference, February 15-18, Barcelona, Spain
Document Type(s): Poster
Countries: Canada
C:
Y:
Gastrointestinal disorders
2017
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients: Three-Year Results from the COMPANION Study in Gastroenterology Patients
Author(s): Marshall JK1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3
Affiliations(s): 1 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 AbbVie Corporation, St. Laurent, Quebec, Canada
Publication(s): Canadian Digestive Diseases Week 2017 Annual Scientific Conference, March 3-6, Banff, Canada
Document Type(s): Poster
Countries: Canada
Click here for the abstract
C:
Y:
Gastrointestinal disorders
2017
  L:
A:
English
Database Study
  Add to report
 
 
Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease
Author(s): Peyrin-Biroulet L1, Van Assche G2, Gómez-Ulloa D3, García-Álvarez L3, Lara N3, Black CM4, Kachroo S4.
Affiliations(s): 1Gastroenterology Department, Lorraine University, Vandoeuvre, France. 2Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. 3IMS Health, Real-World Evidence Solutions, Barcelona, Spain. 4Center for Observational and Real-World Evidence (CORE), Merck and Co, Inc, Kenilworth, New Jersey.
Publication(s): : Clin Gastroenterol Hepatol. 2016 Jul 5. pii: S1542-3565(16)30372-X. doi: 10.1016/j.cgh.2016.06.025
Document Type(s): Abstract
Countries: 
C:
Y:
Gastrointestinal disorders, Hematology
2016
  L:
A:
English
Review
  Add to report
 
 
Unspecified intestinal malabsorption associated with angiotensin receptor blocker therapy: results from a nationwide, population-based study in Italy and Germany.
Author(s): Ripellino C1, Cataldo N1, Scarpignato C.
Affiliations(s): 1 IMS Health Information Solutions Italy Srl, Milan, Italy.
Publication(s): ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria.
Document Type(s): Poster
Countries: Germany, Italy
C:
Y:
Gastrointestinal disorders
2016
  L:
A:
English
Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis
  Add to report
 
 
BIOLOGICS USE IN CROHN’S DISEASE IN France
Author(s): 1-Morand F, 2-Gaudry JL, 3-Willemin L, 4-Lee XY, 5-Lelli F
Affiliations(s): 1- IMS Health Paris France, 2- IMS Health Boulogne-Billancourt France, 3-Janssen-Cilag Issy-les-Moulineaux France, 4-Janssen-Cilag Birkerod Denmark, Janssen-Cilag Colgno Monzese Italy
Publication(s): 19th ISPOR Congress 2016
Document Type(s): Abstract, Poster
Countries: France
C:
Y:
Clinical practice, Gastrointestinal disorders
2016
  L:
A:
English
Retrospective database analysis, Survey research
  Add to report
 
 
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study.
Author(s): Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations(s): 1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address: peyrinbiroulet@gmail.com. 2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom. 10IMS Health, Real World Evidence Solutions, Spain. 11Merck & Co., Inc., Kenilworth, NJ, United States
Publication(s):  Dig Liver Dis. 2016 Jun;48(6):601-7.
Document Type(s): Article
Countries: Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK
C:
Y:
Gastrointestinal disorders
2016
  L:
A:
English
Burden of illness, Patient questionnaire, Survey research
  Add to report
 
 
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study
Author(s): Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations(s): 1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be. 2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica and Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK. 10IMS Health, Real World Evidence Solutions, Barcelona, Spain. 11Merck & Co., Inc., Rahway, NJ, United States.
Publication(s): Dig Liver Dis. 2016 Jun;48(6):592-600
Document Type(s): Article
Countries: Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK
C:
Y:
Gastrointestinal disorders
2016
  L:
A:
English
Burden of illness, Patient questionnaire
  Add to report
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Author(s): Latour M1, Gerega S2, Millson B2, Bessette L3, Marshall JK4, Lebovic G5,6, Sung M2, Oraichi D2, Gaetano T1, Gazel S1, Laliberté MC1
Affiliations(s): 1 AbbVie Corporation, St. Laurent, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 Department of Medicine, Laval University, Quebec City, Quebec, Canada 4 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 5 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
Publication(s): American College of Gastroenterology 2016 Conference, October 14-19, Las Vegas, USA
Document Type(s): Poster
Countries: Canada
Click here for the abstract
C:
Y:
Gastrointestinal disorders, Medication compliance
2016
  L:
A:
English
Database Study
  Add to report
 
 
Socioeconomic variation in the incidence of childhood coeliac disease in the UK.
Author(s): Zingone F1, West J2, Crooks CJ2, Fleming KM2, Card TR2, Ciacci C3, Tata LJ2.
Affiliations(s): Division of Epidemiology and Public Health, City Hospital Campus, University of Nottingham
Publication(s): Arch Dis Child. 2015 Jan 22. pii: archdischild-2014-307105. doi: 10.1136/archdischild-2014-307105 100(5):466-73
Document Type(s): Article
Countries: UK
Click here for the abstract
C:
Y:
Gastrointestinal disorders, Pediatrics
2015
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett’s oesophagus: a populationbased case–control study
Author(s): Masclee GM1, Coloma PM2, Spaander MC3, Kuipers EJ3, Sturkenboom MC4.
Affiliations(s): 1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. 2Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands. 3Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. 4Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands
Publication(s): BMJ Open. 2015 Jan 29;5(1):e006640.
Document Type(s): Article
Countries: Netherlands, UK
Click here for the abstract
C:
Y:
Gastrointestinal disorders, Oncology
2015
  L:
A:
English
Epidemiological study, Retrospective database analysis
  Add to report
 
 
 1 of 9 Next Page Last Page